Skip to main content
. 2017 Mar 31;33(3):477–489. doi: 10.1093/ndt/gfx043

FIGURE 7.

FIGURE 7

Change from baseline in TKV and eGFR by genotype. (A) Percentage change in TKV from TEMPO 3:4 baseline to Month 24 in TEMPO 4:4 for subjects with PKD2 (left panel), PKD1 non-truncating (NT, middle panel) and PKD1 truncating (T, right panel) genotypes. (B) Change in eGFR from TEMPO 3:4 baseline to Month 24 in TEMPO 4:4 for subjects PKD2 (left panel), PKD1 non-truncating (NT, middle panel) and PKD1 truncating (T, right panel) genotypes. Open circles and triangles represent off-treatment time points.